NovaBridge Biosciences (NBP) EV to EBITDA (2020 - 2026)
NovaBridge Biosciences (NBP) EV to EBITDA (2020 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EV to EBITDA |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
-925.78 |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
-570,648.79 |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
-154,826.82 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
-148,087.45 |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
-46,794.65 |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
-281,892.54 |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
22.98 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
-310.38 |
| 10 |
NovaBridge Biosciences |
330.39 Mn |
119.55 Mn |
- |
-1.49 |
| Date | Value |
|---|
| Jun 18, 2026 |
-1.49 |
| Jun 17, 2026 |
-1.66 |
| Jun 16, 2026 |
-1.50 |
| Jun 15, 2026 |
-1.41 |
| Jun 12, 2026 |
-1.46 |
| Jun 11, 2026 |
-1.50 |
| Jun 10, 2026 |
-1.56 |
| Jun 9, 2026 |
-1.75 |
| Jun 8, 2026 |
-1.64 |
| Jun 5, 2026 |
-1.89 |
| Jun 4, 2026 |
-2.32 |
| Jun 3, 2026 |
-2.18 |
| Jun 2, 2026 |
-2.08 |
| Jun 1, 2026 |
-2.66 |
| May 29, 2026 |
-3.08 |
| May 28, 2026 |
-3.18 |
| May 27, 2026 |
-3.18 |
| May 26, 2026 |
-3.15 |
| May 22, 2026 |
-2.83 |
| May 21, 2026 |
-2.88 |
